Resistance to cytotoxic chemotherapy-induced apoptosis in human prostate cancer cells is associated with intracellular clusterin expression

Oncology Reports

Volumn 10, Issue 2, 2003, Pages 469-473

  Miyake, Hideaki ^a   Hara, Isao ^b   Kamidono, Sadao ^b   Gleave, Martin E ^c   Eto, Hiroshi ^a  

^a HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Apoptosis; Chemotherapy; Clusterin; Prostate cancer

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; CHAPERONE; CLU PROTEIN, HUMAN; CLUSTERIN; GLYCOPROTEIN; MONOCLONAL ANTIBODY; PACLITAXEL;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIVISION; DRUG COMBINATION; DRUG EFFECT; DRUG RESISTANCE; GENETICS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; NEOPLASM; PATHOLOGY; PROSTATE TUMOR;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL DIVISION; CLUSTERIN; DRUG COMBINATIONS; DRUG RESISTANCE, NEOPLASM; GLYCOPROTEINS; HUMANS; MALE; MOLECULAR CHAPERONES; NEOPLASMS, HORMONE-DEPENDENT; OLIGONUCLEOTIDES, ANTISENSE; PACLITAXEL; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0037810710     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.2.469     Document Type: Article

References (15)

1. Rosenberg ME and Silkensen J: Clusterin: physiologic and pathophysiologic considerations. Int J Biochem Cell Biol 27: 633-645, 1995.
2. Connor J, Buttyan R, Olsson CA, D'Agati V, O'Toole K and Sawczuk IS: SGP-2 expression as a genetic marker of progressive cellular pathology in experimental hydronephrosis. Kidney Int 39: 1098-1103, 1991.
3. Kyprianou N, English HF, Davidson NE and Isaacs JT: Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res 51: 162-166, 1991.
4. Schwochau GB, Nath KA and Rosenberg ME: Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties. Kidney Int 53: 1647-1653, 1998. (Pubitemid 28243748)
5. French LE, Sappino AP, Tschopp J and Schifferli JA: Distinct sites of production and deposition of the putative cell death marker clusterin in the human thymus. J Clin Invest 90: 1919-1925, 1992.
6. Miyake H, Nelson C, Rennie PS and Gleave ME: Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer. Cancer Res 60: 170-176, 2000. (Pubitemid 30058748)
7. Miyake H, Nelson C, Rennie PS and Gleave ME: Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models. Cancer Res 60: 2547-2554, 2000. (Pubitemid 30262451)
8. Miyake H, Chi KN and Gleave ME: Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo. Clin Cancer Res 6: 1655-1663, 2000. (Pubitemid 30305057)
9. Miyake H, Hara I, Kamidono S and Gleave ME: Synergistic chemosensitization and inhibition of tumor growth and metastasis by the antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model. Clin Cancer Res 7: 4245-4252, 2001. (Pubitemid 34044651)
10. Miyake H, Hara S, Zellweger T, Kamidono S, Gleave M and Hara I: Acquisition of resistance to Fas-mediated apoptosis by overexpression of clusterin in human renal cell carcinoma cells. Mol Urol 5: 105-111, 2001. (Pubitemid 32848102)
11. Humphreys DT, Carver JA, Easterbrook-Smith SB and Wilson MR: Clusterin has chaperone-like activity similar to that of small heat shock proteins. J Biol Chem 274: 6875-6881, 1999.
12. Cervellera M, Raschella G, Santilli G, Tanno B, Ventura A, Mancini C, Sevignani C, Calabretta B and Sala A: Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB. J Biol Chem 275: 21055-21060, 2000. (Pubitemid 30481795)
13. Sintich SM, Steinberg J, Kozlowski JM, Lee C, Pruden S, Sayeed S and Sensibar JA: Cytotoxic sensitivity to tumor necrosis factor-α in PC3 and LNCaP prostatic cancer cells is regulated by extracellular levels of SGP-2 (clusterin). Prostate 39: 87-93, 1999. (Pubitemid 29194279)
14. Kolesnick RN, Haimovitz-Friedman A and Fuks Z: The sphingomyelin signal transduction pathway mediated apoptosis for tumor necrosis factor, Fas, and ionizing radiation. Biochem Cell Biol 72: 471-474, 1994.
15. Miyake H, Tolcher A and Gleave ME: Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides. J Natl Cancer Inst 92: 34-41, 2000.